Lu Ding
Ueruemqi, 830017, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
GE11/RGD Dual-Ligand Copper Nanoassemblies Synchronize Cuproptosis and Photothermal Therapy for Targeted Cervical Cancer Ablation.
Journal: Molecular pharmaceutics
Published: April 27, 2026
LncRNA HOXA-AS3 promotes cell proliferation and invasion via targeting miR-218-5p/FOXP1 axis in osteosarcoma.
Journal: Scientific reports
Published: November 28, 2023
Long non-coding RNA Linc00657 up-regulates Skp2 to promote the progression of cervical cancer through lipid reprogramming and regulation of immune microenvironment.
Journal: Cytokine
Published: October 16, 2023
CBX7 is involved in the progression of cervical cancer through the ITGβ3/TGFβ1/AKT pathway.
Journal: Oncology letters
Published: May 22, 2023
Expression and correlation analysis of Skp2 and CBX7 in cervical cancer.
Journal: Journal of clinical pathology
Published: June 07, 2021
MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein.
Journal: Aging
Published: July 13, 2020
Decreased chromobox homologue 7 expression is associated with epithelial-mesenchymal transition and poor prognosis in cervical cancer.
Journal: Open medicine (Warsaw, Poland)
Published: March 31, 2020
CBX7 Inhibits Cell Growth and Motility and Induces Apoptosis in Cervical Cancer Cells.
Journal: Molecular therapy oncolytics
Published: June 06, 2019
S-phase kinase-associated protein 2 is involved in epithelial-mesenchymal transition in methotrexate-resistant osteosarcoma cells.
Journal: International journal of oncology
Published: November 23, 2017
S-phase kinase-associated protein 2 promotes cell growth and motility in osteosarcoma cells.
Journal: Cell cycle (Georgetown, Tex.)
Published: August 04, 2017
Inhibition of Skp2 suppresses the proliferation and invasion of osteosarcoma cells.
Journal: Oncology reports
Published: August 25, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026